Accelerate your clinical trial assay and CDx development programmes in haematological malignancies by partnering with OGT’s precision medicine team Discover more

At OGT we know that behind every sample is a life that can be improved through the right care decisions. It is our goal to enable researchers and clinical decision makers worldwide to reach …

Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 1,040 FISH probes for hematology, solid tumor, cytogenetics and rare disease, …

Number of tests required Probe strategy Additional information Keep up-to-date with the latest news from OGT

Nov 10, 2025 · Find out about the latest news from OGT, including product launches and updates, new research projects, and other major company updates.

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter.

OGT specializes in the development of superior hybrid capture technology that excels in the detection of complex structural variants and eliminates inaccurate calls caused by alternative …

Want to know why OGT is such a great place to work? Here you can discover more about the different teams that make OGT tick, including R&D, Computational Biology and Operations.

Developed by scientists, for scientists, experience the superior hybridization-based approach of OGT's SureSeq™ portfolio for hematology, solid tumor and constitutional genetics, with pre …

Developed by scientists, for scientists, OGT's CytoCell ® portfolio offers a comprehensive range of over 545 FISH probes for haematology, solid tumour, cytogenetics and rare disease, …